September 3, 2024
In a groundbreaking move, a Colorado Springs church is pushing the boundaries of spirituality by incorporating magic mushrooms into their religious practices. This unconventional approach has sparked both fascination and controversy as the congregation explores the potential of psychedelics to enhance spiritual experiences. Dive into the full story to discover how this innovative blend of faith and science is challenging traditional beliefs and reshaping the future of religious practice. Learn more.
August 22, 2024
Psilocybin is making waves as a transformative tool for mental health and personal growth in the latest blog from Dr. Bronner’s. The article delves into the potential of magic mushrooms to heal and inspire, drawing on both scientific research and personal stories. Click to explore how this powerful compound is changing lives and redefining wellness. Learn more.
August 22, 2024
Recent research confirms that magic mushrooms can effectively treat depression, offering a promising alternative for those struggling with conventional treatments. The study highlights psilocybin’s powerful impact on mood and mental well-being, suggesting it could reshape depression therapy. Click to uncover the compelling evidence and future implications of this breakthrough in mental health treatment. Learn more.
August 21, 2024
New findings suggest that psilocybin, the psychedelic compound in magic mushrooms, could be a game-changer in treating depression by acting similarly to traditional antidepressants but with unique benefits. Researchers are excited about its potential to provide quicker and more profound relief for those struggling with severe depressive symptoms. Click to explore how psilocybin might revolutionize the approach to mental health treatment. Learn more.
August 21, 2024
New research reveals that psilocybin, the active compound in magic mushrooms, may offer a breakthrough treatment for depression, even for those who haven’t responded to conventional therapies. The study highlights psilocybin’s potential to deliver fast and lasting relief, potentially transforming mental health care. Click to discover how this innovative approach could change the landscape of depression treatment. Learn more.
August 21, 2024
Researchers have discovered that psilocybin, the psychedelic compound found in magic mushrooms, shows promising potential for alleviating depressive symptoms in patients resistant to traditional treatments. This groundbreaking study highlights how psilocybin could reshape mental health therapy by providing rapid and lasting relief. Dive into the article to explore the transformative implications of this emerging treatment. Learn more.
August 19, 2024
Colorado has just finalized groundbreaking regulations for the legal use of magic mushrooms, marking a significant shift in drug policy. These new rules outline how the psychedelic compound can be used for therapeutic purposes and set a framework for its safe administration. Click to uncover how these changes could pave the way for a new era in mental health treatment and personal freedom. Learn more.
August 10, 2024
Discover how “Moms of Mushrooms” is transforming mental health care through groundbreaking psilocybin research. This innovative group of scientists and advocates is exploring the profound benefits of psychedelic therapy, challenging traditional views and opening new doors for treatment. Click to see how their pioneering efforts could redefine mental health care as we know it. Learn more.
August 13, 2024
Olympia is making headlines as it moves to decriminalize psychedelic plants and fungi, a groundbreaking decision that could reshape local drug policies and treatment options. This bold initiative aims to provide new pathways for mental health and personal growth, reflecting a growing trend towards re-evaluating the role of psychedelics in society. Discover how this decision could influence the future of drug decriminalization and mental health reform in your community! Learn more.
August 1, 2024
The city council of Redondo Beach, California, has just voted to keep the conversation going about psilocybin mushrooms, marking a significant step in the debate over psychedelic policy. This decision could pave the way for groundbreaking changes in how psilocybin is regulated and used. Click to find out how this development might impact future discussions and what it means for the local community. Learn more.
JULY 30, 2024
Curious about how psilocybin transforms brain activity? This insightful article reveals the latest imaging research that shows the psychedelic’s profound effects on brain connectivity and consciousness. Click to explore what these findings mean for our understanding of the brain and the potential benefits of psilocybin therapy. Learn more.
JULY 29, 2024
Discover how moms are turning to magic mushrooms for a new approach to self-care in this eye-opening article. With a growing trend of psilocybin micro-dosing, these mothers are exploring its potential benefits for enhancing mood and managing stress. Click to learn how this unconventional therapy is reshaping their lives and challenging traditional wellness norms. Learn more.
JULY 23, 2024
Uncover how psilocybin is making waves in addiction research by potentially reducing alcohol use through changes in brain gene expression. This groundbreaking study highlights how the psychedelic compound influences the brain’s reward center, offering new hope for treatment strategies. Click to dive into the fascinating science behind this promising development and its implications for overcoming alcohol dependence. Learn more.
JULY 18, 2024
Explore a new study on psilocybin’s impact on the brain, revealing lasting changes in neural connections linked to improved well-being and mental health. This research suggests that psychedelic experiences could offer enduring benefits by enhancing brain flexibility and resilience. Click to learn more about the potential implications for future therapies and mental health treatments. Learn more.
JULY 17, 2024
Discover groundbreaking research revealing how psilocybin, the active compound in magic mushrooms, influences the brain over weeks, offering new insights into its therapeutic potential. The study highlights long-lasting changes in brain connectivity that could explain the lasting positive effects reported by users. Click to delve into the implications for mental health treatments and the future of psychedelic research. Learn more.
JULY 5, 2024
Explore the evolving landscape of psilocybin therapy through the insights of a mental health counselor in Bend, Oregon, who discusses both the advancements and barriers in this emerging field. Gain perspective on how psilocybin-assisted therapy is reshaping mental health treatment options, navigating legal challenges, and paving the way for potential breakthroughs in patient care. Click to learn more about the counselor’s experiences and the promising future of psychedelic therapy. Learn more.
JUNE 28, 2024
Two new reports reveal that psilocybin-containing mushrooms are now the most popular hallucinogen, with many opting for microdosing, including tech workers and suburban moms. One study highlights a 1,250% increase in interest in microdosing since 2015, while another estimates that 3% of Americans used psilocybin last year. The impact of decriminalization is evident as nearly half of those users chose to microdose. Learn more.
JUNE 21, 2024
A groundbreaking study reveals that psilocybin, found in magic mushrooms, may enhance our ability to learn and explore by increasing exploratory behavior without impairing learning. This discovery highlights psilocybin’s potential to boost cognitive flexibility and optimize therapeutic approaches for mental health conditions. Learn more.
JUNE 19, 2024
A new study from OHSU has established best practices for supervised psilocybin use, ensuring safety and effectiveness. The study, involving 36 seasoned psilocybin facilitators, identified 22 key measures for high-quality services, including safety indicators and client outcomes. As more states consider legalizing psychedelics, these guidelines provide a crucial framework for policymakers and service providers to monitor and optimize psilocybin programs. Learn more.
JUNE 18, 2024
UC Berkeley has launched a groundbreaking study using neuroimaging to explore how psilocybin, the active compound in magic mushrooms, alters brain function. This landmark research aims to understand the brain’s construction of reality under the influence of psychedelics, potentially paving the way for advanced treatments for mental health disorders. Learn more.
JUNE 16, 2024
Older adults who have used psychedelics show improved executive functioning, suggesting potential cognitive benefits beyond traditional psychiatric treatments. This study underscores the need for further research into psychedelic therapies as viable options for cognitive enhancement and mental health support in aging populations. Dive into the findings to understand how these substances could redefine approaches to cognitive health in older adults. Learn more.
JUNE 3, 2024
Stuttering can significantly impact various aspects of life, and traditional therapies often have limited success. A recent preliminary investigation explored the potential benefits of classic psychedelics like psilocybin for stuttering and found that 74% of users reported positive short-term effects, such as reduced stuttering and anxiety. Learn more.
may 21, 2024
Psychedelic-assisted therapy is revolutionizing addiction treatment, addressing both substance dependencies and behavioral addictions through groundbreaking research. Highlighting the transformative potential of psychedelics like psilocybin, studies suggest significant reductions in addictive behaviors and cravings, paving the way for new hope in addiction recovery. With ongoing trials exploring various substances and methodologies, the future promises tailored, effective treatments that could reshape how we approach addiction globally. Learn more.
May 4, 2024
Psilocybin shows potential as an effective treatment for depression, according to recent studies. Research indicates that psilocybin can significantly reduce depressive symptoms with just one or two doses, offering a promising alternative to traditional antidepressants. In a large clinical trial, a 25-milligram dose of psilocybin provided notable relief for individuals with treatment-resistant depression, with some patients experiencing sustained benefits three months post-treatment. Learn more.
Apr 30, 2024
Seattle’s pioneering move to decriminalize magic mushrooms is sparking nationwide interest in alternative approaches to mental health treatment. The city’s new policy reflects growing support for psychedelic therapies, aiming to prioritize wellness and reduce criminalization. Explore how Seattle’s bold step could influence future drug policies and mental health care practices across the United States. Learn more.
Feb 28, 2024
In Oregon, psilocybin treatment is unfolding as a groundbreaking real-time experiment in mental health care, offering hope and controversy. With licensed facilitators guiding participants through therapeutic journeys, this initiative aims to explore the potential of psychedelics in addressing depression and anxiety. Discover how Oregon’s innovative approach could shape the future of psychedelic-assisted therapy in the United States. Learn more.
New research published in the Journal of Psychopharmacology has offered valuable insights into the long-term effects of psilocybin-assisted psychotherapy for depression. The study reports more than half the original cohort were still in remission 12 months after the acute psychedelic treatment.
Psychedelic drugs creating hopes for breakthroughs in depression, anxiety, pain and addiction are being tested at UAB. The university is one of a handful in the nation conducting trials with psilocybin, the active ingredient in hallucinogenic mushrooms.
Psychedelic treatments for addiction challenge 12-step’s ideas about what sobriety is: total abstinence from any mood- or mind-altering drug—psychedelics included.
Single dose of psilocybin leads to decreased demoralisation and improved spiritual wellbeing among cancer sufferers, long-term research indicates
It was mid-morning when Carol Vincent, the owner of a small marketing firm in Victoria, British Columbia, sat down and swallowed a capsule full of pure, synthesized psilocybin. Many people are familiar with the “natural” version, found in so-called magic mushrooms, which have effects similar to LSD and are banned under federal law. Vincent, though, was part of a formal scientific experiment, run by a team from Johns Hopkins University, to see if the drug
Following up on their landmark 2016 study, researchers at NYU Grossman School of Medicine found that a one-time, single-dose treatment of psilocybin, a compound found in psychedelic mushrooms, combined with psychotherapy, appears to be associated with significant improvements in emotional and existential distress in people with cancer. These effects persisted nearly five years after the drug was administered.
Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been steadily making their way back into the lab for a revamped 21st-century-style look. Scientists are rediscovering what many see as the substances’ astonishing therapeutic potential for a vast range of issues, from depression to drug addiction and acceptance of mortality.
Psychedelic drug psilocybin, found in magic mushrooms, is as good at reducing symptoms of depression as conventional treatment, a small, early-stage study has suggested.
In a new study, Yale researchers show that a single dose of psilocybin given to mice prompted an immediate and long-lasting increase in connections between neurons. The findings are published July 5 in the journal Neuron.